New Jersey 2024-2025 Regular Session

New Jersey Assembly Bill A3852

Introduced
2/22/24  

Caption

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.

Impact

The potential impact of A3852 on state laws is substantial, as it proposes to amend existing statutes related to the distribution of educational funds. By introducing measures to increase funding for certain districts, the bill aims to create a more equitable education system. This realignment could lead to significant changes in the way educational institutions are financed, affecting everything from teacher salaries to classroom resources.

Summary

A3852 is a legislative bill aimed at reforming funding mechanisms for public education within the state. The primary objective of the bill is to provide additional resources to underfunded school districts, thereby enhancing educational opportunities for students. By shifting the funding structure, the bill seeks to address disparities in educational quality and ensure that all students have access to necessary learning materials and support systems.

Sentiment

The sentiment surrounding A3852 is generally supportive among educators and advocacy groups who champion the bill as a necessary reform. They argue that the current funding structure disproportionately affects low-income districts, hindering student performance and educational outcomes. However, there is also some opposition, particularly from fiscal conservatives who express concern about the long-term financial implications and sustainability of increased funding levels.

Contention

Key points of contention include debates over the sources of funding for the proposed increases and the mechanisms for measuring the effectiveness of the changes. Opponents argue that without clear accountability measures, the bill may not achieve its intended goals of improving student performance. Supporters, however, emphasize that providing adequate funding is foundational to fostering a successful educational environment and that accountability can be appropriately managed through oversight mechanisms.

Companion Bills

NJ S2283

Same As "Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.

NJ S2934

Carry Over "Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness; decriminalizes, and expunges past offenses involving, psilocybin production, possession, use, and distribution.

NJ A4911

Carry Over "Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness; decriminalizes, and expunges past offenses involving, psilocybin production, possession, use, and distribution.

Previously Filed As

NJ S2283

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.

NJ A4911

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness; decriminalizes, and expunges past offenses involving, psilocybin production, possession, use, and distribution.

NJ S2934

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness; decriminalizes, and expunges past offenses involving, psilocybin production, possession, use, and distribution.

NJ SCR5

Requesting The Department Of Health To Convene A Medicinal Psilocybin And Psilocin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Psilocin And Develop A Long-term Strategic Plan To Ensure The Availability Of Medicinal Psilocybin And Psilocin Or Psilocybin-based And Psilocin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients.

NJ SR3

Requesting The Department Of Health To Convene A Medicinal Psilocybin And Psilocin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Psilocin And Develop A Long-term Strategic Plan To Ensure The Availability Of Medicinal Psilocybin And Psilocin Or Psilocybin-based And Psilocin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients.

NJ SCR227

Requesting The Department Of Health To Convene A Medicinal Psilocybin And Psilocin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Psilocin And Develop A Long-term Strategic Plan To Ensure The Availability Of Medicinal Psilocybin And Psilocin Or Psilocybin-based And Psilocin-based Products That Are Safe, Accessible, And Affordable For Eligible Adult Patients.

NJ HB2400

Relating To Psilocybin.

NJ SB3160

Relating To Psilocybin.

NJ SB1454

Relating To Psilocybin.

NJ SB1454

Relating To Psilocybin.

Similar Bills

NJ S2283

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.

NJ A4911

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness; decriminalizes, and expunges past offenses involving, psilocybin production, possession, use, and distribution.

NJ S2934

"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness; decriminalizes, and expunges past offenses involving, psilocybin production, possession, use, and distribution.

IL SB3695

ILLINOIS CURE ACT

IA HF620

A bill for an act relating to the production of psilocybin and the administration of psilocybin to persons with post-traumatic stress disorder, and providing penalties.(See HF 978.)

IA HF978

A bill for an act relating to the production and administration of psilocybin, and providing penalties. (Formerly HF 620.)

IL HB1143

ILLINOIS CURE ACT

IL SB2184

USE AND RESEARCH-ENTHEOGENS